Delivery Order 75H70522D00007-75H70524F06003
- Not listed
- The Indian Health Service awarded a Delivery Order valued at $276,833.92 to Cepheid Inc. for the period of July 1, 2025 through June 30, 2026 under a CLSU Task Order vehicle. This firm fixed-price delivery order, issued on July 2, 2025, with no set-aside designation, will be performed at a facility in Cass Lake, Minnesota. Cepheid, headquartered in Sunnyvale, California, is a leading manufacturer of advanced molecular diagnostic systems and reagents specializing in infectious disease...
- Cepheid has been awarded a $57,739.26 firm fixed price delivery order by the Department of Health and Human Services Indian Health Service (IHS) for the period of September 1, 2022 through August 31, 2023. This order is being issued against an existing IHS base contract held by Cepheid, and provides for the delivery of products and services in support of IHS clinical diagnostic programs, consistent with the terms and conditions of the underlying vehicle. As the original equipment manufacturer,...
- Cepheid has been awarded a $138,720 firm fixed price delivery order against the CEPHEID AGENCY-WIDE IDIQ vehicle with the Department of Health and Human Services Indian Health Service. As the prime contractor, Cepheid will provide its full range of molecular diagnostic testing equipment, reagents, consumables and associated services to support the clinical diagnostic programs of the Indian Health Service. Cepheid is a manufacturer and global provider of molecular diagnostic solutions for...
- The Indian Health Service awarded a $25,025.20 firm fixed-price purchase order to Cepheid Inc. for lab supplies on April 21, 2026, with completion targeted for June 30, 2026. This order covers invoices #9001936012 and #9001970129 and will be performed at the Cass Lake, Minnesota facility. The contract carries no set-aside designation, reflecting Cepheid's competitive standing in federal molecular diagnostics procurement. This purchase order represents a routine supply acquisition within...
- The Indian Health Service awarded a purchase order to Cepheid Inc. for clinical laboratory supplies with a ceiling value of $679,320 under a firm fixed-price contract. The award, announced on May 15, 2024, covers a performance period from January 1, 2024 through December 31, 2024, with an ultimate completion date of May 14, 2025. This contract modification represents a closeout action and includes no set-aside designation. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale,...
- Cepheid has been awarded a purchase order contract from the Department of Health and Human Services Indian Health Service to provide services under Quote CSQN-00003275. Valued at $23,914.50, this firm fixed price contract has a completion date of March 3, 2028 and was awarded on February 28, 2023 without a set-aside designation. As the prime contractor, Cepheid will deliver molecular diagnostic solutions and associated maintenance and support services to the agency's clinical diagnostic programs...
- The Indian Health Service awarded Cepheid Inc. a delivery order valued at $1.76M under the agency's Multiple Award Schedule contract for molecular diagnostic testing supplies and equipment repair services. This Modification 4 exercise of Option 2 covers the period from January 1, 2024, through December 31, 2024, with an ultimate completion date of March 31, 2029. The delivery order, structured as a firm fixed-price contract with no set-aside designation, will be performed at Cepheid's...
- Cepheid was awarded a $175,000 firm fixed price blanket purchase agreement (BPA) call contract by the Department of Health and Human Services Indian Health Service to provide laboratory diagnostic products and services. The contract has a one-year period of performance beginning January 6, 2023 through January 5, 2024. Headquartered in Sunnyvale, California, Cepheid will deliver its diagnostic testing platforms and assays as part of IHS's efforts to improve health services and outcomes for...
- The Indian Health Service awarded Cepheid Inc. a delivery order valued at $10,200.00 on October 27, 2021, for Fiscal Year 2022 COVID-19 testing kits. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2021, represents a continuation of IHS's procurement of molecular diagnostic testing solutions to support tribal healthcare operations. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as a primary federal supplier of...
- Cepheid has been awarded a $327,886.72 firm fixed price delivery order contract by the Department of Health and Human Services Indian Health Service, with a period of performance through February 4, 2024. The award was made against Cepheid's existing GSA Schedule contract for scientific equipment and services. As the original equipment manufacturer, Cepheid will provide diagnostic testing equipment, reagents, consumables and associated maintenance and support services to support the Indian...
- 75H70522D00007Indefinite Delivery Contract
- 75H70522D00007-75H70524F06003Delivery Order
Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a delivery order valued at $242,163.20 by the Indian Health Service (IHS) for Option Year Two of a contract covering laboratory supplies and testing services. The award, issued on July 2, 2024, covers the period from September 1, 2024, through August 31, 2025, with an ultimate completion date of August 31, 2028. The contract utilizes a firm fixed-price pricing model with no set-aside designation and is being performed in Cass Lake, Minnesota. This delivery order represents a continuation of Cepheid's supply of diagnostic testing solutions to the IHS, which falls under the Department of Health and Human Services and serves American Indian and Alaska Native communities across the nation. Cepheid's core offerings under this award include laboratory supplies and molecular diagnostic testing capabilities, consistent with the company's established product portfolio of GeneXpert diagnostic systems, reagents, and test kits used for detecting infectious diseases and medical conditions. The Indian Health Service, as the funding and contracting agency, utilizes such diagnostic solutions across its healthcare facilities to support clinical testing and disease detection initiatives. This delivery order demonstrates the continued relationship between Cepheid and IHS for molecular diagnostics support, aligning with the company's broader federal contracting history with multiple health agencies including the Department of Veterans Affairs and Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($72k) | 11/25/25 | |
| P00001 | Other Administrative Action | $0 | 10/24/24 | |
| Not listed | Not listed | $313.9k | 7/3/24 |